The Roundup Cancer Settlement Is Still Paying Out — and Thousands of New Claims Are Still Being Filed

This spring, any rural co-op in Iowa or Missouri will still have the recognizable yellow-and-green jugs stacked waist-high behind the seed corn along the back wall. Roundup is still available. Farmers continue to purchase it by the pallet. However, a settlement worth up to $7.25 billion, one of the biggest product-liability agreements in American agricultural history, is still pending approval somewhere in a St. Louis courthouse.

The length of time this story has been developing is easily forgotten. When Bayer acquired Monsanto in 2018, it inherited what many analysts at the time described as a good deal. Within a year, the deal had changed as the first significant jury verdicts began to come in.

Detail	Information
Product at the Center	Roundup (glyphosate-based weedkiller)
Original Manufacturer	Monsanto (St. Louis, Missouri)
Current Owner	Bayer AG (acquired Monsanto in 2018)
CEO of Bayer	Bill Anderson
Active Ingredient	Glyphosate
Alleged Illness	Non-Hodgkin lymphoma
Total Claims Filed to Date	Roughly 200,000
Plaintiffs Who Sued Since 2015	More than 125,000
Latest Proposed Settlement	$7.25 billion (filed in St. Louis Circuit Court)
Payout Period	Up to 21 years in annual installments
Supreme Court Case	Monsanto v. Durnell
Original Durnell Verdict	$1.25 million (Missouri jury, 2023)
Biggest Single Jury Award	$2.1 billion (Georgia, 2025)
Regulator	U.S. Environmental Protection Agency
WHO-IARC Classification (2015)	“Probably carcinogenic to humans”
States Shielding Manufacturers	North Dakota (April 2025), Georgia (May 2025)

Observing it now, it seems that Bayer misjudged how obstinate American juries can be when the plaintiff is a sixty-year-old gardener with non-Hodgkin lymphoma and a garage full of partially used spray bottles. The majority of what’s left will be covered by the recently proposed settlement, which was filed in Missouri earlier this year. The company has been the target of about 200,000 claims. Since 2015 alone, over 125,000 of those have been filed.

Approximately 77,000 had already been settled in two previous, independent settlements. However, new claims continue to come in: those who were diagnosed last year, those who were diagnosed the year before, and those who are just now making the connection between years of weekend yard work and a blood cancer diagnosis.

The disparity in the distribution of the funds is striking. An agricultural worker who has been sprayed for years and is diagnosed with an aggressive form of the disease before turning 60 may be eligible to receive up to $165,000. $20,000 could be awarded to a weekend homeowner with a milder variant who is in their seventies. $10,000 for someone who is 78 years of age or older.

The lawyers argue most loudly about that. Nearly 280 plaintiffs are represented by Matt Clement, who has already stated that he believes the payouts are far too small and that many of his clients will choose not to participate. The difference between what a Georgia jury awarded one plaintiff last year ($2.1 billion) and what the typical claimant will quietly accept on paper is difficult to ignore.

The Supreme Court, which is in charge of everything, is another. Monsanto v. Durnell, a case centered on a Missouri man named John Durnell who won $1.25 million after developing lymphoma as a result of years of neighborhood cannabis spraying, was agreed to be heard by the justices. FIFRA, a federal pesticide law, preempts state courts from requiring cancer warnings that the EPA never mandated, according to Bayer’s limited but profoundly significant argument.

A whole class of failure-to-warn lawsuits, not only against Roundup but also against the majority of pesticides sold in America, might simply disappear if Bayer prevails.

The company appears to have the advantage, according to investors. In contrast to the previous administration, the Trump administration has filed in Bayer’s favor. State legislation protecting pesticide producers who adhere to federal labels has already been passed in North Dakota and Georgia. By the end of 2026, Bayer might finally have the legal closure it has been seeking for almost ten years. It’s also possible that the settlement is upheld if the court makes a different decision, leaving the business vulnerable once more.

The checks continue to be sent out for the time being. Silently, one case at a time. And somewhere, a farmer is probably not even looking at the label as he loads another jug into the back of his truck.